RecruitingNot ApplicableNCT02633553

Adjuvant Radiotherapy for Stage II/III Thymoma After Complete Resection

An Open-label, Multi-center, Randomized Phase III Study of Adjuvant Radiotherapy for Stage II/III Thymoma After Complete Resection

Sponsor

Fudan University

Enrollment

238 participants

Start Date

Jan 10, 2018

Study Type

INTERVENTIONAL

Conditions

Thymoma

Summary

This study is designed to investigate whether adjuvant radiotherapy after complete resection has a better survival for stage II or III thymoma.

Eligibility

Min Age: 18 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying adjuvant radiotherapy for people with thymoma. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 75 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.